A retrospective study evaluating effect of fitness on survival in patients treated with Bortezomib-Based Chemotherapy for Multiple Myeloma
Latest Information Update: 29 Jan 2019
At a glance
- Drugs Bortezomib (Primary) ; Melphalan; Prednisone
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 29 Jan 2019 New trial record
- 04 Dec 2018 Results presented at the 60th Annual Meeting and Exposition of the American Society of Hematology